Last reviewed · How we verify

NCT04667273

Effectiveness of Neuromuscular Electrical Stimulation in Patients With Subacromial Impingement Syndrome

Completed NA Last updated 25 August 2021
What this trial tests

NA trial testing Neuromuscular Electrical Stimulation (NMES) in Subacromial Impingement Syndrome in 48 participants. Completed in 1 June 2021.

Timeline
20 December 2020
Primary endpoint
23 March 2021
1 June 2021

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment48
Start date20 December 2020
Primary completion23 March 2021
Estimated completion1 June 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 65, any sex, with Subacromial Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subacromial Impingement Syndrome (SIS) is one of the musculoskeletal system problems. SIS, which is the most common cause of shoulder pain, constitutes 44-65% of complaints of shoulder pain. Studies have shown that exercise is effective in treating patients with SIS, but the effectiveness and superiority of Neuromuscular Electrical Stimulation (NMES) to each other is uncertain. NMES is widely applied in physiotherapy. In the SIS, the lower trapezius and serratus anterior muscle are affected. Therefore, our aim is to determine the effects of exercises and NMES used in patients with SIS on pain, range of motion (ROM), muscle strength and functional status, neck pain and sleep quality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Neuromuscular Electrical Stimulation (NMES)

Trials testing the same drug.

Other recruiting trials for Subacromial Impingement Syndrome

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04667273.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing